| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 08/16/2001 | WO2001010381A3 Methods for treating or preventing pain and anxiety |
| 08/16/2001 | WO2001009173A3 Use of quinic, shikimic acids and their derivatives for preparing mannose receptor ligands |
| 08/16/2001 | WO2001007628A3 Human synthetases |
| 08/16/2001 | WO2001002569A3 Human immune response molecules |
| 08/16/2001 | WO2000066106A3 Use of benzodiazepines for treating autoimmune diseases induced by apoptosis |
| 08/16/2001 | WO2000057866A3 Use of azalide antibiotics for the topical treatment or prevention of ocular infections |
| 08/16/2001 | WO2000050077A9 Immunogens comprising a peptide and a carrier derived from h.influenzae protein d |
| 08/16/2001 | WO2000047551A3 Inhibitors of aspartyl protease |
| 08/16/2001 | WO2000018355A9 Use of purified invaplex from gram negative bacteria as a vaccine |
| 08/16/2001 | WO2000015212A3 Antifungal activity of dicationic molecules |
| 08/16/2001 | WO2000006739A3 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 08/16/2001 | US20010014689 Nervous system disorders |
| 08/16/2001 | US20010014672 High molecular weight major outer membrane protein of moraxella |
| 08/16/2001 | US20010014454 Novel metal complexes |
| 08/16/2001 | US20010014337 A peptide having substantial homology with the CBF1/RBPJk (cell binding factor-1/recombination bining protein J kappa) interaction domain of EBNA2 comprising specific peptide containing 15-20 amino acids |
| 08/16/2001 | US20010014336 Administering to the warm blooded animal for treating parasitic, bacterial and viral diseases a non-aqueous macrolide compound selected from avermectins and mibemycins |
| 08/16/2001 | US20010014328 A multispecific binding molecule, comprising a first binding determinant which binds an Fc alpha receptor is not blocked by human immunoglobin A and a second binding determinant binds target cancer cell antigen |
| 08/16/2001 | US20010014327 Conjugate molecules are produced by genetic modification of genes encoding light and heavy chains of the surface structure specific antibody and expression in mammal cells to produce the conjugated antibody; enhanced immune response |
| 08/16/2001 | EP1143946A3 Use of benzodiazepines for treating autoimmune diseases induced by apoptosis |
| 08/16/2001 | EP1123935A2 3'-Fluorinated guanosine derivatives for the treatment or prophylaxis of HBV or retroviral infections |
| 08/16/2001 | EP1123927A1 Process for the preparation of bis-(4-amino-1-pyridinium)-alkanes |
| 08/16/2001 | EP1123710A1 Freeze-dried hepatitis a attenuated live vaccine and its stabilizer |
| 08/16/2001 | EP1123708A1 Tear grass-derived antibacterial agent and process for producing the same |
| 08/16/2001 | EP1123707A2 Use of a liver extract and liver extract thereof |
| 08/16/2001 | EP1123692A2 Use of polyaminoacid derivatives for the treatment of Seborrhea and related cutaneous disorders |
| 08/16/2001 | EP1123653A1 Use of polyamino acid derivatives as preservatives |
| 08/16/2001 | EP1123396A2 Minimal promoters and uses thereof |
| 08/16/2001 | EP1123392A1 Prv-1 gene and the use thereof |
| 08/16/2001 | EP1123390A2 Methods and reagents for isolating biologically active peptides |
| 08/16/2001 | EP1123308A1 Single morphic forms of known peptide metalloproteinase inhibitors |
| 08/16/2001 | EP1123294A1 Novel pterin antineoplastic agents |
| 08/16/2001 | EP1123283A1 Thiazole-derivatives |
| 08/16/2001 | EP1123114A1 Virus-like particles for the induction of autoantibodies |
| 08/16/2001 | EP1123113A1 Ribozymes used as prodrugs |
| 08/16/2001 | EP1123091A1 Combination product comprising an e-type prostaglandin ligand and a cox-2 selective inhibitor and methods of use |
| 08/16/2001 | EP1123086A2 Artificial antigen-specific cells and related methods |
| 08/16/2001 | EP1007006A4 Cefadroxil monohydrate tablet formulation |
| 08/16/2001 | EP0944388A4 Inhibitors of farnesyl-protein transferase |
| 08/16/2001 | EP0828715B1 N-oxides as antibacterial agents |
| 08/16/2001 | EP0788498B1 Phenyloxazolidinone antimicrobials |
| 08/16/2001 | EP0765329B1 Rapamycin amidino carbamates and pharmaceutical compositions containing them |
| 08/16/2001 | EP0725634B1 Plaster for the treatment of nail mycoses |
| 08/16/2001 | EP0688330B1 New o-sulfated gangliosides and lyso-ganglioside derivatives |
| 08/16/2001 | EP0677050B1 Novel pyridone carboxylic acid derivatives |
| 08/16/2001 | EP0576483B1 Biocidal proteins |
| 08/16/2001 | DE19955274A1 Verfahren gegen Multiresistenzen und starke Resistenzen Proceedings against multi-drug resistance and strong resistance |
| 08/16/2001 | DE10006139A1 Indol-3-yl-Derivate Indol-3-yl derivatives |
| 08/16/2001 | CA2800450A1 Antibodies that bind human interleukin-18 and methods of making and using |
| 08/16/2001 | CA2635489A1 Drug delivery apparatus |
| 08/16/2001 | CA2400583A1 Porcine reproductive and respiratory syndrome virus and methods of use |
| 08/16/2001 | CA2400488A1 Methods for the prevention and treatment of infections using anti-c3b(i) antibodies |
| 08/16/2001 | CA2400299A1 Dna encoding human vanilloid receptor vr3 |
| 08/16/2001 | CA2400187A1 Protein c derivatives |
| 08/16/2001 | CA2399689A1 Gene cluster encoding a nystatin polyketide synthase and its manipulation and utility |
| 08/16/2001 | CA2399640A1 Selective n-acylation of a82846 glycopeptide analogs |
| 08/16/2001 | CA2399593A1 Antibodies to ccr5 |
| 08/16/2001 | CA2399396A1 Tnf- .alpha. inhibitors |
| 08/16/2001 | CA2399148A1 Antibodies that bind human interleukin-18 and methods of making and using |
| 08/16/2001 | CA2399136A1 1h-imidazopyridine derivatives |
| 08/16/2001 | CA2399019A1 Proteins producing an altered immunogenic response and methods of making and using the same |
| 08/16/2001 | CA2398984A1 Use of glutamate and/or a glutamate precursor for the preparation of a nutritional or pharmaceutical preparation for the treatment or prevention of hyperpermeability or undesired permeability of the intestinal wall |
| 08/16/2001 | CA2398282A1 Method and reagent for the modulation and diagnosis of cd20 and nogo gene expression |
| 08/16/2001 | CA2397254A1 Interferon-alpha induced genes |
| 08/16/2001 | CA2395648A1 Oxazolidinone thioamides with piperazine amide substituents |
| 08/15/2001 | CN1308675A Immunological reagent specifically interating with the extracellular domain of the human zeta chain |
| 08/15/2001 | CN1308635A Novel cyclosporin with improved activity profile |
| 08/15/2001 | CN1308632A 'Beta'-carboline compound |
| 08/15/2001 | CN1308617A Antiviral macrocyclic compounds |
| 08/15/2001 | CN1308547A Novel compositions |
| 08/15/2001 | CN1308546A Immunomodulators for vaccines |
| 08/15/2001 | CN1308543A Oxidized thymosin beta 4 |
| 08/15/2001 | CN1308542A Sucoinamide inhibitors of interleukin-1& beta, converting enzyme |
| 08/15/2001 | CN1308532A Mycobacterial inhibitors |
| 08/15/2001 | CN1308531A Vitamin E and esters thereof for use in the topical treatment of mucosal pathologies |
| 08/15/2001 | CN1308086A Antibiotic/antiendotoxic mimic peptide and its preparation and application |
| 08/15/2001 | CN1308071A Bicyclic DNA gyrase inhibitor |
| 08/15/2001 | CN1308067A Preparation method of methylol hydantoin composite with low content of free formaldehyde |
| 08/15/2001 | CN1308047A Compound capable of being used in treating MRSA and VRE germ infection and its synthesis |
| 08/15/2001 | CN1307902A Varicella preventing method using vaccine |
| 08/15/2001 | CN1307883A Chinese medicine for treating lymph tuberculosis |
| 08/15/2001 | CN1307877A Plaster for cold |
| 08/15/2001 | CN1307875A Chinese medicine preparation for treating chronic myocarditis |
| 08/15/2001 | CN1307873A Coated Gongyanping tablet in special shape and its making process |
| 08/15/2001 | CN1069643C Naphthyridine derivatives and their analogues inhibiting cytomegalovirus |
| 08/15/2001 | CN1069545C Antiseptic and antivirotic medicinal composition and preparation process thereof |
| 08/15/2001 | CN1069521C Improvement of auxiliary material containing chlorohaxanpyridine acetate |
| 08/14/2001 | US6274719 Polynucleotides and polypeptides of the glycopeptidase family; human streptococci microbe diseases targets for development of antibiotics; otitis media, conjunctivitis, pneumonia, bacteremia, meningitis, sinusitis, endocarditis |
| 08/14/2001 | US6274718 Porphyromonas gingivalis arginine-specific proteinase coding sequences |
| 08/14/2001 | US6274716 Combinatorial library of moenomycin analogs and methods of producing same |
| 08/14/2001 | US6274715 Semisynthetic macrolides, useful in bacterial infections treatment and prevention, has less potential for developing resistance, improved or modified profiles of desired gram-negative activity |
| 08/14/2001 | US6274635 Antitumor agents |
| 08/14/2001 | US6274630 Administering polyamine |
| 08/14/2001 | US6274613 Cyclic imines as pesticides |
| 08/14/2001 | US6274595 Compositions for treating infection using optically pure (S)-lomefloxacin |
| 08/14/2001 | US6274589 L-β-dioxolane uridine analogs and their pharmaceutical compositions |
| 08/14/2001 | US6274361 A polynucleotide encoding a polypeptide sequence for a peptidyl-trna hydrolase; diagnosis and therapy for staphylococcal infections; screening antibiotics, vaccines |
| 08/14/2001 | US6274322 Transfection kit; for use as nucleotide sequence tool during genetic engineering |
| 08/14/2001 | US6274177 Preparing crude liquid from rhizomes of ginger by extraction with organic solvent or by distillation with steam; introducing to reverse phase chromatography column, and eluting column with water; removing eluents; extraction |
| 08/14/2001 | US6274173 Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole |
| 08/14/2001 | US6274149 Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence |